微信

English
 

主要论文

2023年代表性论文

时间:2024年04月11日

来源:

浏览:

1.Tingdong Li#, Fugui Li#, Xiaoyi Guo#, Congming Hong#, Xia Yu, Biaohua Wu, Shifeng Lian, Liuwei Song, Jiabao Tang, Shunhua Wen, Kaimin Gao, Mengling Hao, Weimin Cheng, Yingying Su, Shiyin Zhang, Shoujie Huang, Mujin Fang, Yingbin Wang, Mun-Hon Ng, Honglin Chen, Wenxin Luo, Shengxiang Ge*, Jun Zhang, Ningshao Xia*, Mingfang Ji*. Anti-Epstein-Barr Virus BNLF2b for Mass Screening of Nasopharyngeal Cancer. The New England Journal of Medicine. 2023;389(9):808-819. (IF 158.5)

2.Fengcai Zhu#, Shoujie Huang#, Xiaohui Liu#, Qi Chen#, Chunlan Zhuang#, Hui Zhao#, Jinle Han#, Anjuli May Jaen, Thai Hung Do, Jonathan Grant Peter, Alexander Gonzalez Dorado, Louie S Tirador, Gelza Mae A Zabat, Ralph Elvi M Villalobos, Gemalyn Pineda Gueco, Lauren Livia Greta Botha, Shirley Patricia Iglesias Pertuz, Jiaxiang Tan, Kongxin Zhu, Jiali Quan, Hongyan Lin, Yue Huang, Jizong Jia, Xiafei Chu, Junyu Chen, Yixin Chen, Tianying Zhang*, Yingying Su*, Changgui Li*, Xiangzhong Ye*, Ting Wu*, Jun Zhang*, Ningshao Xia*. Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Respiratory Medicine. 2023;11(12):1075-1088. (IF 76.2)

3.Fengcai Zhu#, Guohua Zhong#, Weijin Huang#, Kai Chu, Li Zhang, Zhaofeng Bi, Kongxin Zhu, Qi Chen, Tingquan Zheng, Minglei Zhang, Sheng Liu, Jinbo Xu, Hongxing Pan, Guang Sun, Fengzhu Zheng, Qiufen Zhang, Xiumei Yi, Sijie Zhuang, Shoujie Huang, Huirong Pan*, Yingying Su*, Ting Wu*, Jun Zhang*, Ningshao Xia*. Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trial. The Lancet Infectious Diseases. 2023;23(11):1313-1322. (IF 53.6)

4.Changrong Shi#, Qianyu Zhang#, Yuying Yao, Fantian Zeng, Chao Du, Sureya Nijiati, Xuejun Wen, Xinyi Zhang, Hongzhang Yang, Haoting Chen, Zhide Guo, Xianzhong Zhang, Jinhao Gao, Weisheng Guo*, Xiaoyuan Chen*, Zijian Zhou*. Targeting the activity of T cells by membrane surface redox regulation for cancer theranostics. Nature Nanotechnology. 2023;18(1):86-97. (IF 39.2)

5.Shiqi Chen#, Zehong Huang#, Yue Guo#, Huilin Guo#, Lijuan Jian#, Jin Xiao, Xiangyang Yao, Hai Yu, Tong Cheng, Yali Zhang*, Ming Guan*, Richeng Mao*, Jiming Zhang*, Ningshao Xia*, Quan Yuan*. Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies. Cell Discovery. 2023;9(1):86. (IF 33.5)

6.Lin Xia#, Lunzhi Yuan#, Yahong Hu#, Junyi Liu#, Guosheng Hu#, Ruoyao Qi#, Tianying Zhang, Hualong Xiong, Zaozao Zheng, Hongwei Lin, Jiamo Zhang, Chao Yu, Ming Zhou, Jian Ma, Tong Cheng, Rirong Chen, Yi Guan, Ningshao Xia*, Wen Liu*. A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19. Cellular & Molecular Immunology. 2023;20(4):351-364. (IF 24.1)

7.Hwan-Ching Tai*, Chih-Hui Chang, Wenjie Cai, Jer-Horng Lin, Shing-Jong Huang, Qianyan Lin, Eric Chung-Yueh Yuan, Shuli Li, Ying-Chung Jimmy Lin, Jerry Chun Chung Chan*, Cheng-Si Tsao*. Wood cellulose microfibrils have a 24-chain core-shell nanostructure in seed plants. Nature Plants. 2023;9(7):1154-1168. (IF 18.0)

8.Yang Huang#, Hui Sun#, Shuzhen Wei#, Lanlan Cai, Liqin Liu, Yanan Jiang, Jiabao Xin, Zhenqin Chen, Yuqiong Que, Zhibo Kong, Tingting Li, Hai Yu, Jun Zhang, Ying Gu, Qingbing Zheng*, Shaowei Li*, Rui Zhang*, Ningshao Xia*. Structure and proposed DNA delivery mechanism of a marine roseophage. Nature Communications. 2023;14(1):3609. (IF 16.6)

9.Liang Zhang#, Yao Jiang#, Jinhang He#, Junyu Chen#, Ruoyao Qi#, Lunzhi Yuan#, Tiange Shao#, Hui Zhao#, Congjie Chen, Yaode Chen, Xijing Wang, Xing Lei, Qingxiang Gao, Chunlan Zhuang, Ming Zhou, Jian Ma, Wei Liu, Man Yang, Rao Fu, Yangtao Wu, Feng Chen, Hualong Xiong, Meifeng Nie, Yiyi Chen, Kun Wu, Mujin Fang, Yingbin Wang, Zizheng Zheng, Shoujie Huang, Shengxiang Ge, Shih Chin Cheng, Huachen Zhu, Tong Cheng, Quan Yuan, Ting Wu*, Jun Zhang*, Yixin Chen*, Tianying Zhang*, Changgui Li*, Hai Qi*, Yi Guan*, Ningshao Xia*. Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters. Nature Communications. 2023;14(1):4117. (IF 16.6)

10.Fantian Zeng, Sureya Nijiati, Yangtengyu Liu, Qinqin Yang, Xiaomin Liu, Qianyu Zhang, Shi Chen, Anqi Su, Hehe Xiong, Changrong Shi, Congbo Cai, Zhongning Lin, Xiaoyuan Chen*, Zijian Zhou*. Ferroptosis MRI for early detection of anticancer drug-induced acute cardiac/kidney injuries. Science Advances. 2023;9(10):eadd8539. (IF 15.0)

11.Junping Hong#, Ling Zhong#, Liqin Liu#, Qian Wu#, Wanlin Zhang#, Kaiyun Chen#, Dongmei Wei#, Hui Sun, Xiang Zhou, Xinyu Zhang, Yinfeng Kang, Yang Huang, Junyu Chen, Guosong Wang, Yan Zhou, Yanhong Chen, Qisheng Feng, Hai Yu, Shaowei Li, Mu-Sheng Zeng, Yixin Zeng*, Miao Xu*, Qingbing Zheng*, Yixin Chen*, Xiao Zhang*, Ningshao Xia*. Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection. Cell Reports Medicine. 2023;4(11):101296. (IF 14.3)

12.Zhaojun Mo#, Shoujie Huang#, Lingxian Qiu#, Changgui Li#, Xiaojuan Yu#, Mingqiang Li, Zhen Chen, Guohua Zhong, Dequan Pan, Lirong Huang, Bangjun Lv, Xuelian Cui, Qiaoqiao Song, Jizong Jia, Jinle Han, Wei Wang, Hua Zhu, Tong Cheng, Yingying Su, Yimin Li, Xiangzhong Ye*, Ting Wu*, Jun Zhang*, Ningshao Xia*. Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial. The Lancet Regional Health-Western Pacific. 2023;34:100707. (IF 7.1)

13.Kai Chu#, Zhaofeng Bi#, Weijin Huang#, Yafei Li#, Li Zhang, Changlin Yang, Hanmin Jiang, Xia Zang, Qi Chen, Donglin Liu, Hongxing Pan, Yue Huang, Fengzhu Zheng, Qiufen Zhang, Guang Sun, Yingying Su, Shoujie Huang*, Huirong Pan*, Ting Wu*, Yuemei Hu*, Jun Zhang , Fengcai Zhu, Ningshao Xia. Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial. The Lancet Regional Health-Western Pacific. 2023;34:100731. (IF 7.1)

14.Kangguo Li#, Feng Ruan#, Zeyu Zhao#, Zhinan Guo#, Zimei Yang, Shanshan Yu, Buasiyamu Abudunaibi, Xuebao Zhang, Xiling Yin, Wenhua Mei*, Tianmu Chen*. Comparative analysis of transmission and vaccine effectiveness in Omicron and Delta variant outbreaks in China. Journal of Infection. 2023;86(1):66-117. (IF 28.2)

15.Yichao Guo#, Zeyu Zhao#, Shiting Yang#, Xiaohao Guo, Tianmu Chen*. Feasibility of emulating Singapore's experience during the Omicron wave in China. Journal of Infection. 2023;86(3):256-308. (IF 28.2)

16.Kangguo Li#, Demeng Wang#, Huimin Qu#, Jia Rui#, Buasiyamu Abudunaibi, Zhinan Guo, Sihan Wu, Guzainuer Abudurusuli, Zimei Yang, Kang Fang, Yidun Zhang, Chenghao Su*, Tianmu Chen*. Viral dynamics of omicron BA.2.76 variant of SARS-CoV-2 in a cohort of COVID-9 patients. Journal of Infection. 2023;86(2):154-225. (IF 28.2)

17.Hui Sun#, Tingting Deng#, Yali Zhang#, Yanling Lin#, Yanan Jiang#, Yichao Jiang#, Yang Huang, Shuo Song, Lingyan Cui, Tingting Li, Hualong Xiong, Miaolin Lan, Liqin Liu, Yu Li, Qianjiao Fang, Kunyu Yu, Wenling Jiang, Lizhi Zhou, Yuqiong Que, Tianying Zhang, Quan Yuan, Tong Cheng, Zheng Zhang, Hai Yu, Jun Zhang, Wenxin Luo, Shaowei Li*, Qingbing Zheng*, Ying Gu*, Ningshao Xia*. Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD. Protein & Cell. 2023;15(2):121-134. (IF 21.1)

18.Xuqi Peng, Yating Zheng, Yi Xue, Xiaoliu Liang, Pan He, Hu Chen, Peng He, Yisheng Peng, Zhenwen Zhao, Yulun Chen, Xiran Gui, Lei Yang, Yongfu Xiong, Juan Lin, Yesi Shi, Chengchao Chu, Yang Zhang*, Gang Liu*. Super-Stable Homogeneously Sustained-Release System Mediates Transcatheter Arterial Ionic-Embolization Strategy for Hepatocellular Carcinoma Therapy. Advanced Functional Materials, 2023;2311505. (IF 19.0)

19.Xiao Xu, Hu Chen, Zhenwen Zhao, Yangjie Wang, Pan He, Hongwei Cheng, Xing Gao, Yesi Shi, Yesen Li, Jinxiong Huang, Yisheng Peng, Chengchao Chu, Yang Zhang, Chao Liu, Bo Li, Jingsong Mao*, Hongjuan Ma*, Gang Liu*. Engineering Radioactive Microspheres for Intra-Arterial Brachytherapy Using Radiation-Induced Graft Polymerization. Advanced Functional Materials, 2023;33(50):2306215. (IF 19.0)

20.Xiao Xu, Hu Chen, Pan He, Zhenwen Zhao, Xing Gao, Chao Liu, Hongwei Cheng, Lai Jiang, Peiyu Wang, Yang Zhang, Xiaofei Wen, Yesen Li, Jinxiong Huang, Yongfu Xiong, Jingsong Mao, Hongjuan Ma*, Gang Liu*. 3D Hollow Porous Radio-Granular Hydrogels for SPECT Imaging-Guided Cancer Intravascular Brachytherapy. Advanced Functional Materials, 2023;33(22):2215110. (IF 19.0)

21.Yuemei Hu#, Zhaofeng Bi#, Ya Zheng#, Li Zhang#, Fengzhu Zheng, Kai Chu, Yafei Li, Qi Chen, Jiali Quan, Xiaowen Hu, Xingcheng Huang, Kongxin Zhu, Yahui Wangjiang, Hanmin Jiang, Xia Zang, Donglin Liu, Changlin Yang, Hongxing Pan, Qiufen Zhang, Yingying Su, Shoujie Huang, Guang Sun*, Weijin Huang*, Yue Huang*, Ting Wu*, Jun Zhang, Ningshao Xia. Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial. Science Bulletin (Beijing). 2023;68(20):2448-2455. (IF 18.9)

22.Yutian Xia#, Jianzhong Zhang#, Gang Liu*. A prospective strategy leveraging nanomedicine for cancer therapy: pouring ferroptosis on apoptosis. Nano Today. 2023;48:101740. (IF 17.4)

23.Fajun Li#, Junping Hong#, Chaoheng Guan, Kaiyun Chen, Yinong Xie, Qian Wu, Junjie Chen, Baichang Deng, Jiaqing Shen, Xueying Liu, Rongsheng Hu, Yulong Zhang, Yixin Chen*, Jinfeng Zhu*. Affinity Exploration of SARS-CoV-2 RBD Variants to mAb-Functionalized Plasmonic Metasurfaces for Label-Free Immunoassay Boosting. ACS Nano. 2023;17(4):3383-3393. (IF 17.1)

24.Xiaomin Liu, Mingkun Wang, Yichao Jiang, Xinyi Zhang, Changrong Shi, Fantian Zeng, Yatong Qin, Jinmin Ye, Jiaying Hu, Zijian Zhou*. Magnetic Resonance Imaging Nanoprobe Quantifies Nitric Oxide for Evaluating M1/M2 Macrophage Polarization and Prognosis of Cancer Treatments. ACS Nano. 2023;17(24):24854-24866. (IF 17.1)

25.Haizhen Ding#, Fangfang Ren#, Peifei Liu#, Yushuo Feng, Xiaoqian Ma, Zhiyang Shen, Qianqian Shi, Mengjiao Xu, Wenle Li, Prof. Hongmin Chen*. Cu2+-Anchored Carbon Nano-Photocatalysts for Visible Water Splitting to Boost Hydrogen Cuproptosis. Angewandte Chemie International Edition. 2023;62(44):e202311549. (IF 16.6)

26.Fantian Zeng#, Sureya Nijiati#, Longguang Tang#, Jinmin Ye, Zijian Zhou*, Xiaoyuan Chen*. Ferroptosis Detection: From Approaches to Applications. Angewandte Chemie International Edition. 2023;62(35):e202300379. (IF 16.6)

27.Wenjing Sun#, Chengchao Chu#, Shi Li, Xiaoqian Ma, Peifei Liu, Shileng Chen, Hongmin Chen*. Nanosensitizer-Mediated Unique Dynamic Therapy Tactics for Effective Inhibition of Deep Tumors. Advanced Drug Delivery Reviews. 2023;192:114643. (IF 16.1)

28.Peng He#, Sha Yi#, Jianzhong Zhang#, Chengchao Chu, Xuqi Peng, Changhong Li, Xinfei Sun, Yang Zhang*, Hongwei Cheng*, Xia Xiong*, Gang Liu*. Carrier-free 5-Fu nanoparticle-mediated domestication therapy for scar treatment: A preclinical and first-in-human study. Chemical Engineering Journal. 2023;475:146061. (IF 15.1)

29.Xuan Liu, Lunzhi Yuan, Jijing Chen, Yali Zhang, Peiwen Chen, Ming Zhou, Jiaxuan Xie, Jian Ma, Jianzhong Zhang, Kun Wu, Qiyi Tang, Quan Yuan, Huachen Zhu*, Tong Cheng*, Yi Guan*, Gang Liu*, Ningshao Xia*. Antiviral Nanobiologic Therapy Remodulates Innate Immune Responses to Highly Pathogenic Coronavirus. Advanced Science. 2023;10(17):e2207249. (IF 15.1)

30.Yuan Liu, Peishi Rao, Hongyan Qian, Yesi Shi, Shiju Chen, Jingying Lan, Dan Mu,Rongjuan Chen, Xinwei Zhang, Chaoqiong Deng, Gang Liu*, Guixiu Shi*. Regulatory Fibroblast-Like Synoviocytes Cell Membrane Coated Nanoparticles: A Novel Targeted Therapy for Rheumatoid Arthritis. Advanced Science. 2023;10(4):e2204998. (IF 15.1)

31.Huaping Deng, Han Xu, Yiru Wang, Ruizhen Jia, Xiaoqian Ma, Yushuo Feng, Hongmin Chen*. G-quadruplex-based CRISPR photoswitch for spatiotemporal control of genomic modulation. Nucleic Acids Research. 2023;51(8):4064-4077. (IF 14.9)

32.Miao Yu#, Xiaoqian Hu#, Zihang Pan, Cui Du, Jing Jiang, Wanshan Zheng, Han Cai, Yinan Wang, Wenbo Deng, Haibin Wang, Jinhua Lu, Mingan Sun*, Bin Cao*. Endogenous retrovirus-derived enhancers confer the transcriptional regulation of human trophoblast syncytialization. Nucleic Acids Research. 2023;51(10):4745-4759. (IF 14.9)

33.Xiaoxiao Shi, Dazhuang Xu, Hongwei Cheng, Chengchao Chu*, Gang Liu*. Recent Advances in Interventional Fluorescence Imaging: Toward the Precise Visualization of Transarterial Mini-Invasive Delivery Systems. Accounts of Materials Research. 2023;4(3): 251-263. (IF 14.6)

34.Huaan Li, Fei Peng*, Xiaohui Yan*, Chun Mao*, Xing Ma*, Daniela A. Wilson*, Qiang He*, Yingfeng Tu*. Medical micro- and nanomotors in the body. Acta Pharmaceutica Sinica B. 2023;13(2):517-541. (IF 14.5)

35.Jie Wei#, Jintao Liu#, Huan Wang#, Kai Wen, Xiuye Ni, Yilong Lin, Jingru Huang, Xiang You, Zhao Lei, Juan Li, Heqing Shen*, Yi Lin*. Nanoplastic propels diet-induced NAFL to NASH via ER-mitochondrial tether-controlled redox switch. Journal of Hazardous Materials. 2023;465:133142. (IF 13.6)

36.Lin Che#, Jing Huang#, Jinxian Lin#, Chiyu Xu, Xinmou Wu, Zebang Du, Jiashen Wu, Zhongning Lin*, Yuchun Lin*. Aflatoxin B exposure triggers hepatic lipotoxicity via p53 and perilipin 2 interaction-mediated mitochondria-lipid droplet contacts: An in vitro and in vivo assessment. Journal of Hazardous Materials. 2023;445:130584. (IF 13.6)

37.Zhonghua Lu#, Bin Sun#, Yixin Wang*, Yaru Wu, Yujie Chen, Shengzhi Sun, Shijia Liang, Song Xu, Hao Chang, Henggui Chen, Jie Zhang*. Ozone exposure associates with sperm quality indicators: Sperm telomere length as a potential mediating factor. Journal of Hazardous Materials. 2023;459:132292. (IF 13.6)

38.Dong Ying#, Qiyu He#, Weikun Tian#, Yanling Chen#, Xiaoping Zhang, Siling Wang, Chang Liu, Zihao Chen, Yu Liu, Lijuan Fu, Li Yan, Ling Wang, Zimin Tang*, Lin Wang, Zizheng Zheng*, Ningshao Xia*. Urine Is a Viral Antigen Reservoir in Hepatitis E Virus Infection. Hepatology. 2023;77(5):1722-1734. (IF 13.5)

39.Gan Lin, Jiajing Zhou, Hongwei Cheng, Gang Liu*. Smart Nanosystems for Overcoming Multiple Biological Barriers in Cancer Nanomedicines Transport: Design Principles, Progress, and Challenges. Small. 2023;19(28):e2207973. (IF 13.3)

40.Dazhuang Xu, Jianlin Ge, Yibo An, Shuang Bai, Ziying Wang, Shuaiying Wu, Qixuan Dai, Zhixiang Lu*, Gang Liu*. Molecular Engineering of NIR-II/IIb Emitting AIEgen for Multimodal Imaging-Guided Photo-Immunotherapy. Small. 2023;19(32):e2300859. (IF 13.3)

41.Guohua Zhong#, Chunlan Zhuang#, Xiaowen Hu, Qi Chen, Zhaofeng Bi, Xinhua Jia, Siying Peng, Yufei Li, Yue Huang, Qiufen Zhang, Ying Hong, Youlin Qiao, Yingying Su, Huirong Pan, Ting Wu, Lihui Wei, Shoujie Huang*, Jun Zhang, Ningshao Xia. Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial. Emerging Microbes & Infections. 2023;12(1):2185456. (IF 13.2)

42.Qian Wu#, Ling Zhong#, Dongmei Wei#, Wanlin Zhang#, Junping Hong#, Yinfeng Kang, Kaiyun Chen, Yang Huang, Qingbing Zheng, Miao Xu, Mu-Sheng Zeng, Yi-Xin Zeng, Ningshao Xia, Qinjian Zhao, Claude Krummenacher*, Yixin Chen*, Xiao Zhang*. Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes. Emerging Microbes & Infections. 2023;12(2):2245920. (IF 13.2)

43.Zimin Tang#, Guiping Wen#, Dong Ying, Siling Wang, Chang Liu, Weikun Tian, Yingbin Wang, Mujin Fang, Yulin Zhou, Yunsheng Ge, Ting Wu, Jun Zhang, Shoujie Huang*, Zizheng Zheng*, Ningshao Xia*. Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study. Emerging Microbes & Infections. 2023;12(1):2140613. (IF 13.2)

44.Hui Sun#, Yizhen Wang#, Xiuting Chen#, Yanan Jiang, Siling Wang, Yang Huang, Liqin Liu, Yu Li, Miaolin Lan, Huilin Guo, Quan Yuan, Yali Zhang, Tingting Li, Hai Yu, Ying Gu, Jun Zhang, Shaowei Li*, Zizheng Zheng*, Qingbing Zheng*, Ningshao Xia. Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant. Journal of Virology. 2023;97(11):e0113723. (IF 12.7)

45.Bo Qian#, Lin Che#, Zebang Du#, Nijun Guo#, Xinmou Wu, Lei Yang, Zhaoxuan Zheng, Yunlu Gao, Mingzhu Wang, Xiaoxuan Chen, Ling Xu, Zijian Zhou*, Yuchun Lin*, Zhongning Lin*. Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling. Theranostics. 2023;13(12):4288-4302. (IF 12.4)

46.Hongzhang Yang, Lei Zhang, Huanhuan Liu, Yunming Zhang, Zhaobiao Mou, Xueyuan Chen, Jingchao Li, Fengming He, Zijing Li*. Simplified one-pot 18F-labeling of biomolecules with in situ generated fluorothiophosphate synthons in high molar activity. Theranostics. 2023;13(2):472-482. (IF 12.4)

47.Lai Jiang#*, Linyu Ding#, Gang Liu*. Nanoparticle formulations for therapeutic delivery, pathogen imaging and theranostic applications in bacterial infections. Theranostics. 2023;13(5):1545-1570. (IF 12.4)

48.Pan He#, En Ren#, Biaoqi Chen#, Hu Chen#, Hongwei Cheng, Xing Gao, Xiaoliu Liang, Hao Liu, Jingdong Li, Bo Li, Aizheng Chen, Chengchao Chu, Xiaoyuan Chen, Jingsong Mao*, Yang Zhang*, Gang Liu*. A super-stable homogeneous Lipiodol-hydrophilic chemodrug formulation for treatment of hepatocellular carcinoma. Theranostics. 2023;12(4): 1769-1782. (IF 12.4)

49.Peiyu Wang#, Renwu Zhou#, Rusen Zhou#, Shuo Feng, Liqian Zhao, Wenshao Li, Jinyong Lin, Aleksandra Rajapakse, Chia-Hwa Lee, Frank B. Furnari, Antony W. Burgess, Jennifer H.  Gunter, Gang Liu, Kostya (Ken) Ostrikov, Derek J. Richard, Fiona Simpson, Xiaofeng Dai*, Erik W. Thompsonb. Epidermal growth factor potentiates EGFR(Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium. Redox Biology. 2023;69:102976. (IF 11.4)

50.Guosong Wang#, Jiali Cao#, Mengxuan Gui#, Pengfei Huang#, Liang Zhang#, Ruoyao Qi, Ruiqi Chen, Lina Lin, Qiangyuan Han, Yanhua Lin, Tian Chen, Peiqing He, Jian Ma, Rao Fu, Junping Hong, Qian Wu, Hai Yu, Junyu Chen, Chenghao Huang, Tianying Zhang, Quan Yuan, Jun Zhang*, Yixin Chen*, Ningshao Xia*. The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors. Journal of Experimental & Clinical Cancer Research. 2023;42(1):284. (IF 11.3)

51.Meifeng Nie#, Shuyu Wu#, Yiyi Chen#, Yangtao Wu#, Ruitong Chen, Yue Liu, Mingxi Yue, Yao Jiang, Dekui Qiu, Man Yang, Zikang Wang, Jiahua Gao, Hualong Xiong, Ruoyao Qi, Jinhang He, Jinlei Zhang, Liang Zhang, Yingbin Wang, Mujin Fang, Yuqiong Que, Youliang Yao, Shaowei Li*, Jun Zhang*, Qinjian Zhao*, Quan Yuan*, Tianying Zhang*, Ningshao Xia*. Micronanoparticled risedronate exhibits potent vaccine adjuvant effects. Journal of Controlled Release. 2023;365:369-383. (IF 10.8)

52.Yang Zhang#, Jing Luo#, Xiran Gui#, Yating Zheng, Eric Schaar, Gang Liu*, Jinjun Shi*. Bioengineered nanotechnology for nucleic acid delivery. Journal of Controlled Release. 2023;364:124-141. (IF 10.8)

53.Changrong Shi, Xinyi Zhang, Xiaomin Liu, Xiaoyuan Chen*, Zijian Zhou*. Theranostics on the immunoactivity of T cells. Clinical and Translational Medicine. 2023;13(9):e1421. (IF 10.6)

54.Dongxu Zhang, Yang Yan, Yulin Huang, Bowen Liu, Qingbing Zheng, Jun Zhang, Ningshao Xia*. Unsupervised Cryo-EM Images Denoising and Clustering based on Deep Convolutional Autoencoder and K-Means++. IEEE Transactions on Medical Imaging. 2023;42(5):1509-1521. (IF 10.6)

55.Suzhong Fu#, Jing Xu#, Shilong Chang, Luyao Yang, Shuting Ling, Jinghan Cai, Jiayin Chen, Jiacheng Yuan, Ying Cai, Bei Zhang, Zicheng Huang, Kun Yang, Wenhai Sui*, Linyan Xue*, Qingliang Zhao*. Robust vascular segmentation for raw complex images of laser speckle contrast based on weakly supervised learning. IEEE Transactions on Medical Imaging. 2023;43(1):39-50. (IF 10.6)

56.Pan He#, Haitian Tang#, Yating Zheng#, Yongfu Xiong, Hongwei Cheng, Jingdong Li*, Yang Zhang*, Gang Liu*. Advances in nanomedicines for lymphatic imaging and therapy. Journal of Nanobiotechnology. 2023;21(1):292. (IF 10.2)

57.Han Xu, Huaping Deng, Xiaoqian Ma, Yushuo Feng, Ruizhen Jia, Yiru Wang, Yaqing Liu, Wenli Li, Shanshan Meng, Hongmin Chen*. NIR-II-absorbing diimmonium polymer agent achieves excellent photothermal therapy with induction of tumor immunogenic cell death. Journal of Nanobiotechnology. 2023;21(1):132. (IF 10.2)

58.Bing Chen#, Kaifan Zheng#, Shubin Fang#, Kangping Huang, Chengchao Chu, Junyang Zhuang, Jin Lin, Shaoguang Li, Hong Yao, Ailin Liu, Gang Liu*, Jizhen Lin*, Xinhua Lin*. B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC. Journal of Nanobiotechnology. 2023;21(1):378. (IF 10.2)

59.Dong Li*, Shundong Cai, Peiyu Wang, Hongwei Cheng, Bingwei Cheng, Yang Zhang*, Gang Liu*. Innovative Design Strategies Advance Biomedical Applications of Phthalocyanines. Advanced Healthcare Materials. 2023;12(22):e2300263. (IF 10.0)

60.Xin Feng, Long Wei, Yanlin Liu, Xiaoyuan Chen, Rui Tian*. Orchestrated Strategies for Developing Fluorophores for NIR-II Imaging. Advanced Healthcare Materials. 2023;12(24):e2300537. (IF 10.0)

61.Shuaiying Wu, Jianzhong Zhang, Jie Pan, Shuang Bai, Ziying Wang, Yulun Chen, Dazhuang Xu, Yibo An, Chao Liu, Chengchao Chu, Qixuan Dai, Lai Jiang, Zhixiang Lu*, Gang Liu*. Integrated Nanorod-Mediated PD-L1 Downregulation in Combination with Oxidative-Stress Immunogene Therapy against Cancer. Advanced Healthcare Materials. 2023;12(17):e2300110. (IF 10.0)

62.Yibo An, Dazhuang Xu, Xiaofei Wen, Chuan Chen*, Gang Liu*, Zhixiang Lu*. Internal Light Sources-Mediated Photodynamic Therapy Nanoplatforms: Hope for the Resolution of the Traditional Penetration Problem. Advanced Healthcare Materials. 2023;13(1):2301326. (IF 10.0)

63.Huimin Zhu, Jinfa Ye, Yiming Wu, Yuhang Cheng, Min Su, Qixuan Dai, Yun Han 1, Jintao Pan, Zhenyu Wu, Chuan Chen, Chenyue Qiu, Wei Li, Gang Liu*, Chengchao Chu*. A Synergistic Therapy with Antioxidant and Anti-VEGF: Towards Its Safe and Effective Elimination for Corneal Neovascularization. Advanced Healthcare Materials. 2023;2302192. (IF 10.0)

64.Yi-Chen Chiang*, Darui Gao, Chun-Yang Lee, Xian Li, Xinying Sun, Ching-Tsao Chen*. Influence of promoting an "age-friendly cities" strategy on psychological capital and social engagement based on the scenario method. Journal of Aging & Social Policy. 2023;35(4):463-485. (IF 7.1) SSCI

65.Xueru Li#, Zirong Ye#, Haoxiang Lang, Ya Fang*. Climate Change and Depressive Disorders in middle-aged and older people in China: A quasi-experimental study. Journal of Environmental Psychology. 2023;92:102162. (IF 6.9) SSCI

66.Xian Li#, Min Gao#, Meijie Chu#, Shiling Huang, Zhiwei Fang, Tianmu Chen, Chun-Yang Lee*, Yi-Chen Chiang*. Promoting the well-being of rural elderly people for longevity among different birth generations: A healthy lifestyle perspective. Frontiers in Public Health. 2023;11:1050789. (IF 6.5) SSCI

67.Liangwen Zhang#, Ying Han#, Ya Fang*. Non-human and human service efficiency of long-term care facilities in China. Frontiers in Public Health. 2023;11:1066190. (IF 6.5) SSCI

68.Manzhi Lin#, Meijie Chu#, Xian Li, Honghao Ma, Zhiwei Fang, Li Mao, Pengjun Wang, Tianmu Chen, Yi-Chen Chiang*. Factors influencing adolescent experimental and current smoking behaviors based on social cognitive theory: A cross-sectional study in Xiamen. Frontiers in Public Health. 2023;11:1093264. (IF 6.5) SSCI

69.Xiaodong Chen, Lingxiao He, Kewei Shi, Yafei Wu, Shaowu Lin, Ya Fang*. Interpretable Machine Learning for Fall Prediction Among Older Adults in China. American Journal of Preventive Medicine. 2023;65(4):579-586. (IF 5.5) SSCI

70.Kai Wang#, Qianmei Jiang#, Murong Gao#, Xiu’e Wei, Chan Xu, Chengliang Yin, Haiyan Liu, Renjun Gu, Haosheng Wang*, Wenle Li*, Liangqun Rong*. A clinical prediction model based on interpretable machine learning algorithms for prolonged hospital stay in acute ischemic stroke patients: a real-world study. Frontiers in Endocrinology (Lausanne). 2023;14:1165178. (IF 5.2) SSCI

71.Hesong Zhang#, Juhua Dai#, Wei Zhang, Xinping Sun, Yujing Sun, Lu Wang, Hongwei Li*, Jie Zhang*. Integration of clinical demographics and routine laboratory analysis parameters for early prediction of gestational diabetes mellitus in the Chinese population. Frontiers in Endocrinology (Lausanne). 2023;14:1216832. (IF 5.2) SSCI

72.Zirong Ye#, Xueru Li#, Haoxiang Lang, Ya Fang*. Income inequality and depressive symptoms among Chinese adults: a quasi-experimental study. Public Health. 2023;226:58-65. (IF 5.2) SSCI

73.Liangwen Zhang#, Rui Chen#, Ya Fang*. Effects of Urban and Rural Resident Basic Medical Insurance on Healthcare Utilization Inequality in China. International Journal of Public Health. 2023;68:1605521. (IF 5.1) SSCI

74.Zirong Ye, Xueru Li, Haoxiang Lang, Ya Fang*. Long-term PM2.5 exposure, lung function, and cognitive function among middle-aged and older adults in China. Journals of Gerontology Series A-biological Sciences And Medical Sciences. 2023;78(12):2333-2341. (IF 5.1) SSCI



下一篇